Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia

Othman Al-Sawaf

Janina Stumpf

Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Can Zhang

School of Integrated Circuits and Electronics, MIIT Key Laboratory for Low-Dimensional Quantum Structure and Devices

Florian Simon

Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Francesc Bosch

Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona

Emadoldin Feyzi

St. Olavs University Hospital, Department of Hematology, Trondheim, Norway

Paolo Ghia

School of Medicine, Università Vita Salute San Raffaele, Milan

Michael Gregor

Cantonal Hospital of Lucerne, Lucerne, Switzerland

Arnon P. Kater

Amsterdam University Medical Center location University of Amsterdam, Department of Hematology

Vesa Lindström

Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki

Mattias Mattsson

Uppsala University Hospital, Uppsala, Sweden

Carsten U. Niemann

Rigshospitalet, Copenhagen University Hospital, Copenhagen

Philipp B. Staber

Medical University Vienna, Vienna, Austria

Tamar Tadmor

Bnai Zion Medical Center, Technion, Haifa, Israel

Patrick Thornton

Cancer Clinical Trials and Research Unit, Cancer Trials Ireland, Beaumont Hospital, Dublin

Clemens-Martin Wendtner

Ludwig-Maximilians University (LMU), Medical Clinic III, Munich, Germany

Ann Janssens

Universitaire Ziekenhuizen Leuven, Leuven, Belgium

Thomas Noesslinger

Hanusch Krankenhaus, Vienna

Jan-Paul Bohn

Medical University of Innsbruck, Department of Hematology and Oncology, Innsbruck, Austria

Caspar da Cunha-Bang

Rigshospitalet, Copenhagen University Hospital, Copenhagen

Christian B. Poulsen

Zealand University Hospital, Roskilde, Denmark

Juha Ranti

Turku University Hospital, Turku, Finland

Thomas Illmer

Berufsausüebungsgemeinschaft, Gokos, Dresden, Germany

Bjoern Schoettker

Hämatologisch-Onkologische Schwerpunktpraxis, Wuerzburg, Germany

Sebastian Böttcher

Clinic III (Hematology, Oncology, and Palliative Medicine), Rostock University Medical Center, Rostock, Germany

Tobias Gaska

Bruederkrankenhaus Paderborn, Paderborn, Germany

Elisabeth Vandenberghe

Ruth Clifford

University Hospital Limerick, Limerick, Ireland

Ohad Benjamini

Chaim Sheba Medical Center, Ramat Gan, Israel

Anna Maria Frustaci

ASST Grande Ospedale Metropolitano Niguarda, Milan

Lydia Scarfò

School of Medicine, Università Vita Salute San Raffaele, Milan

Paolo Sportoletti

Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncology Research (CREO), University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy

John Schreurs

Martini Ziekenhuis, Groningen, the Netherlands

Mark-David Levin

Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands

Hanneke van der Straaten

Ziekenhuis St Jansdal, Harderwijk, the Netherlands

Marjolein van der Klift

Amphia Ziekenhuis, Breda, the Netherlands

Hoa Tran

Javier de la Serna

Hospital Universitario 12 de Octubre, Madrid

Javier Loscertales

Hospital Universitario La Princesa, Madrid

Oscar Lindblad

Skane University Hospital, Lund, Sweden

Anna Bergendahl Sandstedt

University Hospital Linköping, Linköping, Sweden

Jeroen Goede

KS Winterthur, Winterthur, Switzerland

Michael Baumann

HOCH Health Ostschweiz, Kantonsspital St. Gallen, St. Gallen, Switzerland

Anna Maria Fink

Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Kirsten Fischer

Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Matthias Ritgen

Universitaetsklinikum Schleswig-Holstein, Medizinische Klinik II, Kiel, Germany

Karl-Anton Kreuzer

Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Christof Schneider

Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany

Eugen Tausch

Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany

Stephan Stilgenbauer

Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany

Sandra Robrecht

Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Barbara Eichhorst

Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Michael Hallek

Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany